Exscientia

Exscientia is a company that is committed to getting medicines to patients in the fastest and most effective manner. We do this by applying the latest research in Artificial intelligence (AI), machine learning and modern high-performance computational methods to transform drug design. Exscientia is at the forefront of Artificial Intelligence (AI) driven drug discovery and the only company to have used AI to design drug molecules that are currently in clinical studies.

As a full stack AI drug discovery company, we focus on implementing AI design as well as precision data generation. Together these maximise the power and fidelity of the integrated AI and machine learning systems.

By focusing on both design and experiment, we are able to significantly accelerate the pre-clinical drug discovery stage to enable the delivery of new treatments to patients worldwide.

To find out more, watch this short clip of Andrew Hopkins CEO and Founder of Exscientia explain why he set up Exscientia https://www.exscientia.ai/our-mission